Learning objectives: Identify risk factors for the development of second malignant neoplasms.
Identify the multiple molecular pathways leading to t-MN, and implications for the treatment of both the primary malignant disease and the subsequent myeloid neoplasm.
09/04/2018 - 12:00pm to 1:00pm CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Michelle M. Le Beau, PhD